Urinary estrogen metabolites and breast cancer: A case-control study

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 7, 1997, Pages 505-509

  Kabat, Geoffrey C ^a,c   Chang, Chee Jen ^a   Sparano, Joseph A ^a   Sepkovic, Daniel W ^b   Hu, Xiao Ping ^a   Khalil, Abbas ^a   Rosenblatt, Ruth ^a   Bradlow, H Leon ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; ESTROGEN DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; URINALYSIS;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; HUMANS; HYDROXYESTRONES; MIDDLE AGED; NEW YORK; POSTMENOPAUSE; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 16944365158     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kelsey, J. L., Gammon, M. D., and John, E. M. Reproductive factors and breast cancer. Epidemiol. Rev., 15: 36-47, 1993.
2. Harris, J. R., Lippman, M. E., Veronesi, U., and Willett, W. Breast cancer. N. Engl. J. Med., 327: 319-328, 1993.
3. Bernstein, L., and Ross, R. K. Endogenous hormones and breast cancer risk. Epidemiol. Rev., 15: 48-65, 1993.
4. Hulka, B. S., Liu, E. T., and Lininger, R. A. Steroid hormones and risk of breast cancer. Cancer (Phila.), 74: 1111-1124, 1994.
5. Colditz, G. A. Fat, estrogens, and the time frame for prevention of breast cancer. Epidemiology, 6: 209-211, 1995.
6. Schneider, J., Kinne, D., Fracchia, A., Pierce, V., Anderson, K. E., Bradlow, H. L., and Fishman J. Abnormal oxidative metabolism in women with breast cancer. Proc. Natl. Acad. Sci. USA, 79: 3047-3051, 1982.
7. Telang, N. T., Suto, A., Wong, G. Y. C., Osborne, M. P., and Bradlow, H. L. Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J. Natl. Cancer Inst. (Bethesda), 84: 634-638, 1992.
8. Bradlow, H. L., Hershcopf, R. J., Martucci, C. P., and Fishman, J. Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc. Natl. Acad. Sci. USA, 82: 6295-6299, 1985.
9. Osborne, M. P., Bradlow, H. L., Wong, G. Y. C., and Telang, N. T. Upregulation of estradiol C16α-hydroxylation in human breast tissue: A potential biomarker of breast cancer risk. J. Natl. Cancer Inst. (Bethesda), 85: 1917-1920, 1993.
10. Adlercreutz, H., Fotsis, T., Hockerstedt, K., Hamalainen, E., Bannwart C., Bloigu, S. Valtonen, A., and Ollus, A. Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J. Steroid Biochem., 34: 527-530, 1989.
11. Lemon, H. M., Heidel, J. W., and Rodriguez-Sierra, J. Increased catechol estrogen metabolism as a risk factor for nonfamilial breast cancer. Cancer (Phila.), 69: 457-465, 1992.
12. Schutze, N., Vollmer, G., Tiemann, I., Geiger, M., and Knuppen, R. Catecholestrogens are MCF-7 cell estrogen receptor agonists. J. Steroid Biochem. Mol. Biol., 46: 781-789, 1993.
13. Lottering, M-L., Haag, M., and Seegers, J. C. Effects of 17β-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res., 52: 5926-5932, 1992.
14. Michnovicz, J. J., and Bradlow, H. L. Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J. Natl. Cancer Inst. (Bethesda), 82: 947-949, 1990.
15. Bradlow, H. L., Michnovicz, J. J., Telang, N. T., and Osborne, M. P. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis (Lond.), 12: 1571-1574, 1991.
16. Bradlow, H. L., Sepkovic, D. W., Telang, N. T., and Osborne, M. P. Indole-3-carbinol. A novel approach to breast cancer prevention. Ann. NY Acad. Sci., 768: 180-200, 1995.
17. Bradlow, H. L., Michnovicz, J. J., Halper, M., Miller, D. G., Wong, G. Y. C., and Osborne, M. P. Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol., Biomarkers & Prev. 3: 591-595, 1994.
18. Kojima, T., Tanaka, T., and Mori, H. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res., 54: 1446-1449, 1994.
19. Sepkovic, D. W., Bradlow, H. L., Ho, G., Hankinson, S. E., Gong L., Osborne, M. P., and Fishman, J. Estrogen metabolite ratios and risk assessment of hormone-related cancers: assay validation and prediction of cervical cancer risk, vol. 768, pp. 312-316. Ann. NY Acad. Sci., 1995.
20. Klug, T. L., Bradlow, H. L., and Sepkovic, D. W. Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16α-hydroxyestrone in urine. Steroids 59: 648-655, 1994.
21. Adlercreutz, H., Martin, F., Wahlross, O., and Soini, E. Mass spectrophotometric and mass fragmatographic determination of natural and synthetic steroids in biological fluids. J. Steroid Biochem. Mol. Biol., 6: 247-259, 1975.